Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su Yin Lim

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Cancers|May 9, 2019
Tumour-Derived Laminin α5 (LAMA5) Promotes Colorectal Liver Metastasis Growth, Branching Angiogenesis and Notch Pathway InhibitionAlex Gordon-Weeks, Su Yin Lim, Arseniy Yuzhalin, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 21, 2014
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI studyAnna I Blazejewska, Ali M Al-Radaideh, Sam Wharton, et al.
Brain Sciences|October 28, 2023
Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging StudyRadu Tanasescu, Olivier Mougin, I-Jun Chou, et al.
BMC Public Health|March 7, 2025
Association of COVID-19 infection and COVID-19 vaccination with idiopathic sudden sensorineural hearing loss in Malaysia: a case-control studyNur Sabrina Abdul Rahim, Xin-Jie Lim, E-Li Leong, et al.
Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2019
Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexiaHannah Yejin Kim, Janna K Duong, Maria Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Longitudinal clinical study of patients with iron rim lesions in multiple sclerosisAmjad I Altokhis, Aimee M Hibbert, Christopher M Allen, et al.
Ebiomedicine|August 31, 2024
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitorsSu Yin Lim, Yingxin Lin, Jenny H Lee, et al.
Cancer Cell International|November 26, 2025
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanomaFei Yang, Su Yin Lim, Ines Pires da Silva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2012
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated SyndromeAli M Al-Radaideh, Samuel J Wharton, Su-Yin Lim, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Cancers|May 9, 2019
Tumour-Derived Laminin α5 (LAMA5) Promotes Colorectal Liver Metastasis Growth, Branching Angiogenesis and Notch Pathway InhibitionAlex Gordon-Weeks, Su Yin Lim, Arseniy Yuzhalin, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 21, 2014
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI studyAnna I Blazejewska, Ali M Al-Radaideh, Sam Wharton, et al.
Brain Sciences|October 28, 2023
Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging StudyRadu Tanasescu, Olivier Mougin, I-Jun Chou, et al.
BMC Public Health|March 7, 2025
Association of COVID-19 infection and COVID-19 vaccination with idiopathic sudden sensorineural hearing loss in Malaysia: a case-control studyNur Sabrina Abdul Rahim, Xin-Jie Lim, E-Li Leong, et al.
Cancers|March 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort StudySu Yin Lim, Laura Ferro-López, Elizabeth Barquin, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2019
Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexiaHannah Yejin Kim, Janna K Duong, Maria Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Longitudinal clinical study of patients with iron rim lesions in multiple sclerosisAmjad I Altokhis, Aimee M Hibbert, Christopher M Allen, et al.
Ebiomedicine|August 31, 2024
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitorsSu Yin Lim, Yingxin Lin, Jenny H Lee, et al.
Cancer Cell International|November 26, 2025
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanomaFei Yang, Su Yin Lim, Ines Pires da Silva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2012
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated SyndromeAli M Al-Radaideh, Samuel J Wharton, Su-Yin Lim, et al.
Pageof 7